The Massachusetts-based company was founded by scientists and doctors from prestigious institutions including MIT, Imperial College London, Harvard Medical School, and the University of California at Berkeley. Elemind's wearable has undergone five clinical trials, showing its effectiveness in inducing sleep up to 74% faster and suppressing essential tremor within just 30 seconds of stimulation. The company plans to announce the product in the coming months and continues to fund clinical trials with research institutions.
Key takeaways:
- Elemind, a neurotechnology startup, has raised $12 million in funding for its AI-enhanced neurotech wearable that can improve sleep or calm the mind via brainwave stimulation.
- The wearable reads brainwaves through the skin and modulates electrical signals to the brain through non-invasive stimulation. It has shown potential in suppressing tremors for people with essential tremor and Parkinson’s disease, inducing sleep, increasing pain thresholds, and enhancing the effects of sedation.
- The company has partnered with leading research institutions and has undergone five clinical trials, demonstrating its effectiveness in inducing sleep up to 74% faster and suppressing essential tremor within just 30 seconds of stimulation.
- Elemind has received significant interest from top-tier tech investors and founders, including Village Global, LDV Partners, MIT Investment Fund, and founders of Skype and Nest. The company plans to announce the product in the coming months.